Question 11272 — drugs

Summary

Ms. Huguette Tiegna draws the attention of the Minister of Solidarity and Health to the marketing of cannabidiol (CBD), a substance devoid of the active ingredients listed on the list of narcotics. Indeed, several establishments selling processed cannabidiol-based products with a THC level of less than 0.2% have opened in France. Marketing is limited to the sale of the plant to infuse or inhale, allocated a ban on smoking the product. Furthermore, the WHO issued an opinion in December 2017 on the subject of cannabidiol which “does not appear to have any potential for abuse, nor to be harmful to health”. Likewise, the interministerial mission to combat drugs and addictive behavior issued a negative opinion, on June 11, 2018, regarding the marketing of “products, and in particular e-liquids based on CBD” if they do not are not obtained from authorized plant varieties and parts. Thus, the products marketed are subject to European regulations and listed in the European catalog. The sale of products enriched with cannabidiol being authorized, it wishes to know its position regarding the marketing of hemp flowers (0.2% THC) and their notification within the framework of the exemptions granted for industrial and commercial hemp, while controlling, as is the case for products enriched with cannabidiol, their traceability and, de facto, their quality.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

• Huguette Tiegna · auteur

Related records

No cross-record relationships stored yet.